𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selective aspects of chemotherapy in acute luekemia and Burkitt's tumor

✍ Scribed by David P. Rall


Publisher
John Wiley and Sons
Year
1968
Tongue
English
Weight
485 KB
Volume
21
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term survivors in acute leukemia an
✍ Joseph H. Burchenal πŸ“‚ Article πŸ“… 1968 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 2 views

Of 157 long-term survivors with acute leukemia, 103 are Iiving and well with no evidence of disease (NED) 5 to 17 years from the diagnosis. Of these 103, 48 have been off therapy for a year or more, 43 for 2 or more years, 29 f o r 5 years or more, and 10 f o r 10 years or more. Survival curves sugg

Selective use of daunorubicin for remiss
✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se